Facebook Page Cannot Leave Out Risk Information, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Office of Prescription Drug Promotion also expresses concern that Facebook page for hypothyroidism drug Tirosint fails to include limits on the indication.